ArticleJID innovations : skin science from molecules to population health2026
Identification of serpin B12 as an endogenous inhibitor of epidermal mesotrypsin and its possible role in epidermal desquamation during differentiation.
Article in JID innovations : skin science from molecules to population health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The maintenance of stratum corneum homeostasis requires precise regulation of protease activity, particularly within the desquamation pathway. In this study, we identified serpin B12 as an inhibitor of mesotrypsin in stratum corneum extracts obtained from hyperkeratotic heel skin. liquid chromatography coupled with electrospray ionization tandem mass spectrometry analysis identified serpin B12 as one of the most abundant candidates with known mesotrypsin-inhibitory potential, and recombinant serpin B12 suppressed mesotrypsin activity in a dose-dependent manner. To evaluate its functional relevance in epidermal tissue, we manipulated serpin B12 expression in reconstructed 3-dimensional skin equivalents. Knockdown and overexpression of serpin B12 resulted in marked alterations in stratum corneum thickness, indicating that serpin B12 influences the structural organization of the upper epidermis. Because mesotrypsin modulates kallikrein-related peptidases, which mediate corneodesmosome degradation and desquamation, these findings suggest that serpin B12 contributes to the modulation of stratum corneum homeostasis through the inhibition of mesotrypsin activity. Our results suggest that serpin B12 functions as an epidermal protease inhibitor and provide insight into the molecular mechanisms governing barrier maintenance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.